Company intelligence / Profile preview

Vilex

McMinnville, Tennessee, United States

Ownership: Private
Employees: ~250
Development stage: Other

Overview

Vilex's Hintermann Series H2 and H3 Total Ankle Replacement systems, among other devices, have demonstrated decades of clinical success globally for lower extremity surgical solutions, with over 30,000 TARs implanted. Products such as NITINEX staples are FDA-cleared for hand and foot bone fixation and arthrodesis.

Therapeutic areas: OtherRheumatology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Vilex.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vilex.

Explore the full profile